Preparation of 2-Amino-2-Methyl-1 ,3-Propandiol-Thymolphthalein Monophosphate (AMPD-TMP)
Place 5 g (4.27 mmol) of magnesium thymolphthalein monophosphate (Eastman Kodak, Rochester, N. Y. 14650) in a 500-ml Erlenmeyer flask and add 100 ml of 2 mol/ liter HC1. Stir vigorously until the magnesium salt is well dispersed, add 100 ml of diethyl ether and continue stirring until a uniform suspension is obtained.
Transfer the mixture to a separatory funnel and separate the phases. Extract the aqueous phase with an additional 75 ml of diethyl ether and equilibrate the combined ether extracts with 20 ml of saturated aqueous sodium chloride solution.
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Results and Discussion
Other amines were investigated and with slight modifications of the procedure presented above, salts were obtained from 2-amino-2-methyl-1-propanol, tris(hydroxymethyl)aminomethane, diethanolamine, and dicyclohexylamine. All the salts are white to off-white, free flowing, stable, nonhygroscopic powders. While most of the salts are acceptable for preparation of phosphatase substrates, AMPD-TMP is clearly superior in its properties and its ease of preparation and is shown to be an excellent source of thymolphthalein monophosphate.
AMPD-TMP obtained
by this procedure is largely the monoamine salt, whereas with excess amine the diamine salt is the product. Gun. Chem. 16, 431 (1970 of 16 g/dl of water at 25 #{176}C, and in the presence of acids or bases up to pH 11. Aqueous solutions are neutral in pH and can be sterilized by autoclaving at 120 #{176}C. The weighing factor for this salt is most favorable (see Table 1 ). Magnesium gluconate has been available commercially for pharma-
